Literature DB >> 23867445

Cardiac dysfunction in pneumovirus-induced lung injury in mice.

Reinout A Bem1, Elske van den Berg, Ernst Suidgeest, Louise van der Weerd, Job B M van Woensel, Heynric B Grotenhuis.   

Abstract

OBJECTIVE: To determine biventricular cardiac function in pneumovirus-induced acute lung injury in spontaneously breathing mice.
DESIGN: Experimental animal study.
SETTING: Animal laboratory.
SUBJECTS: C57Bl/6 mice. INTERVENTION: Mice were inoculated with the rodent pneumovirus, pneumonia virus of mice.
MEASUREMENTS AND MAIN RESULTS: Pneumonia virus of mice-infected mice were studied for right and left ventricular function variables by high-field strength (7 Tesla) cardiac MRI at specific time points during the course of disease compared with baseline. One day before and at peak disease severity, pneumonia virus of mice-infected mice showed significant right and left ventricular systolic and diastolic volume changes, with a progressive decrease in stroke volume and ejection fraction. No evidence for viral myocarditis or viral presence in heart tissue was found.
CONCLUSIONS: These findings show adverse pulmonary-cardiac interaction in pneumovirus-induced acute lung injury, unrelated to direct virus-mediated effects on the heart.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23867445     DOI: 10.1097/PCC.0b013e31828a7f9b

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  2 in total

1.  New mouse model of pulmonary hypertension induced by respiratory syncytial virus bronchiolitis.

Authors:  Dai Kimura; Jordy Saravia; Sridhar Jaligama; Isabella McNamara; Luan D Vu; Ryan D Sullivan; Salvatore Mancarella; Dahui You; Stephania A Cormier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-06-15       Impact factor: 4.733

2.  The effect of TIP on pneumovirus-induced pulmonary edema in mice.

Authors:  Elske van den Berg; Reinout A Bem; Albert P Bos; Rene Lutter; Job B M van Woensel
Journal:  PLoS One       Date:  2014-07-21       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.